teaser
Shire plc, the global specialty biopharmaceutical company, today announced its support for inflammatory bowel disease (IBD) fellowships at leading medical institutions across the country. The six fellowships will begin in 2011 and will provide a year of training in the management of IBD to physicians who recently completed a fellowship in gastroenterology.
“We are proud to support the education of future medical professionals,” said Roger Adsett, senior vice president of Shire’s gastroenterology business unit. “As a company committed to advancing gastroenterology, we hope the individuals who complete the Shire-supported fellowships will provide important contributions to bettering patient care.”
Institutions receiving support from Shire in the form of charitable contributions include: Cedars-Sinai Medical Center (Los Angeles), Cleveland Clinic, Mayo Clinic (Rochester, Minn.), Mount Sinai Medical Center (New York), University of California, San Francisco, and University of Chicago Medical Center. Shire selected these Centers of Excellence based on the centers’ existing fellowship programs.
“Thanks to Shire’s generous support, we will be able to increase the number of practicing physicians dedicated to treating inflammatory bowel disease, for which there is a growing need,” said Daniel Present, MD, clinical professor of medicine and gastroenterology, at New York’s Mount Sinai School of Medicine. “Fellowships are vital in generating valuable research and improving patient care.”
The institutions selected the fellowship recipients in June for fellowships that will begin July 2011. Medical students were selected for the fellowships by the individual medical institutions based on pre-existing criteria.
